Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis
Lin Xie(Canadian Heritage), Yun Zhang(Baylor College of Medicine), Peili Bu(Shandong University), Wenhai Sui(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue Lu(Guangzhou University of Chinese Medicine), Wenjing Xiong(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Xi(Ningbo No.6 Hospital), Fei Xue(Shanghai Normal University), Cheng Zhang(Shanghai Sixth People's Hospital), Xiaoyan Yu(Fuzhou University), Lin Zhong(Chongqing University), Jian-Min Yang(Second Military Medical University), Cheng Cheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Linlin Meng(Shandong University), Feng Xu(Shandong First Medical University)
Cited by 34
Related Papers
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
|Cardiovascular Research|2021|270
Drug resistance in ovarian cancer: from mechanism to clinical trial
|Molecular Cancer|2024|233
Peroxiredoxin 2 activates microglia by interacting with Toll-like receptor 4 after subarachnoid hemorrhage
|Journal of Neuroinflammation|2018|155